199 related articles for article (PubMed ID: 36713501)
1. Initial clinical experience with magnetic resonance-guided radiotherapy in pediatric patients: Lessons learned from a single institution with proton therapy.
Hall MD; Mittauer KE; Herrera R; Von Werne K; Kotecha R; Kalman NS; McCulloch J; Alvarez D; McAllister NC; Doty DG; Rzepczynski AE; Deere W; Gutierrez AN; Chuong MD
Front Oncol; 2022; 12():1037674. PubMed ID: 36713501
[TBL] [Abstract][Full Text] [Related]
2. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
[TBL] [Abstract][Full Text] [Related]
3. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic Magnetic Resonance-Guided Adaptive and Non-Adaptive Radiotherapy on Combination MR-Linear Accelerators: Current Practice and Future Directions.
Bryant JM; Weygand J; Keit E; Cruz-Chamorro R; Sandoval ML; Oraiqat IM; Andreozzi J; Redler G; Latifi K; Feygelman V; Rosenberg SA
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046741
[TBL] [Abstract][Full Text] [Related]
5. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
[TBL] [Abstract][Full Text] [Related]
6. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
[TBL] [Abstract][Full Text] [Related]
7. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
[TBL] [Abstract][Full Text] [Related]
8. Feasibility of Adaptive MR-guided Stereotactic Body Radiotherapy (SBRT) of Lung Tumors.
Padgett KR; Simpson GN; Llorente R; Samuels MA; Dogan N
Cureus; 2018 Apr; 10(4):e2423. PubMed ID: 29872603
[TBL] [Abstract][Full Text] [Related]
9. First prospective clinical evaluation of feasibility and patient acceptance of magnetic resonance-guided radiotherapy in Germany.
Klüter S; Katayama S; Spindeldreier CK; Koerber SA; Major G; Alber M; Akbaba S; Debus J; Hörner-Rieber J
Strahlenther Onkol; 2020 Aug; 196(8):691-698. PubMed ID: 32002567
[TBL] [Abstract][Full Text] [Related]
10. Non-Adaptive MR-Guided Radiotherapy for Prostate SBRT: Less Time, Equal Results.
Sandoval ML; Youssef I; Latifi K; Grass GD; Torres-Roca J; Rosenberg S; Yamoah K; Johnstone PA
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362179
[TBL] [Abstract][Full Text] [Related]
11. Real-time Magnetic Resonance-guided Liver Stereotactic Body Radiation Therapy: An Institutional Report Using a Magnetic Resonance-Linac System.
Feldman AM; Modh A; Glide-Hurst C; Chetty IJ; Movsas B
Cureus; 2019 Sep; 11(9):e5774. PubMed ID: 31723533
[TBL] [Abstract][Full Text] [Related]
12. Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience.
Garcia Schüler HI; Pavic M; Mayinger M; Weitkamp N; Chamberlain M; Reiner C; Linsenmeier C; Balermpas P; Krayenbühl J; Guckenberger M; Baumgartl M; Wilke L; Tanadini-Lang S; Andratschke N
Radiat Oncol; 2021 Nov; 16(1):217. PubMed ID: 34775998
[TBL] [Abstract][Full Text] [Related]
13. Marker-less online MR-guided stereotactic body radiotherapy of liver metastases at a 1.5 T MR-Linac - Feasibility, workflow data and patient acceptance.
Gani C; Boeke S; McNair H; Ehlers J; Nachbar M; Mönnich D; Stolte A; Boldt J; Marks C; Winter J; Künzel LA; Gatidis S; Bitzer M; Thorwarth D; Zips D
Clin Transl Radiat Oncol; 2021 Jan; 26():55-61. PubMed ID: 33319073
[TBL] [Abstract][Full Text] [Related]
14. Low Tesla magnetic resonance guided radiotherapy for locally advanced cervical cancer: first clinical experience.
Boldrini L; Piras A; Chiloiro G; Autorino R; Cellini F; Cusumano D; Fionda B; D'Aviero A; Campitelli M; Marazzi F; Balducci M; Valentini V; Gambacorta MA
Tumori; 2020 Dec; 106(6):497-505. PubMed ID: 32066345
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes after online adaptive MR-guided stereotactic body radiotherapy for pancreatic tumors on a 1.5 T MR-linac.
Eijkelenkamp H; Grimbergen G; Daamen LA; Heerkens HD; van de Ven S; Mook S; Meijer GJ; Molenaar IQ; van Santvoort HC; Paulson E; Erickson BA; Verkooijen HM; Hall WA; Intven MPW
Front Oncol; 2023; 13():1040673. PubMed ID: 37854684
[TBL] [Abstract][Full Text] [Related]
16. A prospective registry study of stereotactic magnetic resonance guided radiotherapy (MRgRT) for primary liver tumors.
Bordeau K; Michalet M; Dorion V; Keskes A; Valdenaire S; Debuire P; Cantaloube M; Cabaillé M; Draghici R; Ychou M; Assenat E; Jarlier M; Gourgou S; Guiu B; Ursic-Bedoya J; Aillères N; Fenoglietto P; Azria D; Riou O
Radiother Oncol; 2023 Dec; 189():109912. PubMed ID: 37739315
[TBL] [Abstract][Full Text] [Related]
17. Application of real-time MRI-guided linear accelerator in stereotactic ablative body radiotherapy for non-small cell lung cancer: one step forward to precise targeting.
Kang HJ; Kwak YK; Kim M; Lee SJ
J Cancer Res Clin Oncol; 2022 Nov; 148(11):3215-3223. PubMed ID: 36040666
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study comparing MR-guided radiation therapy (MRgRT) setup strategies for prostate treatment: repositioning vs. replanning.
Kim JI; Park JM; Choi CH; An HJ; Kim YJ; Kim JH
Radiat Oncol; 2019 Aug; 14(1):139. PubMed ID: 31387593
[TBL] [Abstract][Full Text] [Related]
19. Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports.
Dincer N; Ugurluer G; Korkmaz L; Serkizyan A; Atalar B; Gungor G; Ozyar E
Cureus; 2022 Apr; 14(4):e23980. PubMed ID: 35541303
[TBL] [Abstract][Full Text] [Related]
20. Initial clinical applications treating pediatric and adolescent patients using MR-guided radiotherapy.
Kozak MM; Crompton D; Gross BA; Harshman L; Dickens D; Snyder J; Shepard A; St-Aubin J; Dunkerley D; Hyer D; Buatti JM
Front Oncol; 2022; 12():962926. PubMed ID: 36419881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]